Showing 8361-8380 of 8875 for: Cochrane Systematic Reviews Back
- Trastuzumab‐containing regimens for metastatic breast cancer
Cochrane Systematic Reviews, 12-Jun-2014
Patients with breast cancer are classified as having cells that over-express the human epidermal growth factor receptor 2 (known as HER2-positive) or not (HER2-negative). Typically, patients with HER2-positive disease have a worse prognosis. Trastuzumab i
- Trazodone for agitation in dementia
Cochrane Systematic Reviews, 13-May-2008
Behavioural and psychiatric disturbances affect at least 50% of people with Alzheimer's disease and other dementias. Neuroleptic drugs are extensively prescribed to treat behavioural manifestations of dementia in spite of only modest efficacy and a high f
- Treadmill interventions in children under six years of age at risk of neuromotor delay
Cochrane Systematic Reviews, 29-Jul-2017
Delayed motor development may occur in children with Down syndrome, cerebral palsy, general developmental delay or children born preterm. It limits the child's exploration of the environment and can hinder cognitive and social-emotional development. Liter
- Treadmill training and body weight support for walking after stroke
Cochrane Systematic Reviews, 17-Aug-2017
Treadmill training, with or without body weight support using a harness, is used in rehabilitation and might help to improve walking after stroke. This is an update of the Cochrane review first published in 2003 and updated in 2005 and 2014.
- Treadmill training for patients with Parkinson's disease
Cochrane Systematic Reviews, 13-Sep-2015
Treadmill training is used in rehabilitation and is described as improving gait parameters of patients with Parkinson's disease.
- Treating BCG-induced disease in children
Cochrane Systematic Reviews, 6-Dec-2012
Bacillus Calmette-Guerín (BCG) is a live attenuated vaccine to prevent tuberculosis, routinely administered at birth as part of the World Health Organization global expanded immunisation programme. Given intradermally, it can cause adverse reactions, incl
- Treating periodontal disease for preventing adverse birth outcomes in pregnant women
Cochrane Systematic Reviews, 12-Jun-2017
Periodontal disease has been linked with a number of conditions, such as cardiovascular disease, stroke, diabetes and adverse pregnancy outcomes, all likely through systemic inflammatory pathways. It is common in women of reproductive age and gum conditio
- Treating progressive disseminated histoplasmosis in people living with HIV
Cochrane Systematic Reviews, 28-Apr-2020
Progressive disseminated histoplasmosis (PDH) is a serious fungal infection that affects people living with HIV. The best way to treat the condition is unclear.
- Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis
Cochrane Systematic Reviews, 30-Nov-2019
Pouchitis occurs in approximately 50% of patients following ileal pouch-anal anastomosis (IPAA) for chronic ulcerative colitis (UC).
- Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)
Cochrane Systematic Reviews, 31-Oct-2008
Selective serotonin reuptake inhibitors are thought to have better discontinuation rates (i.e. less people dropping out) than tricyclic and heterocyclic antidepressant drugs. It is important to quantify the drop-out rates of different antidepressant drugs
- Treatment for amphetamine dependence and abuse
Cochrane Systematic Reviews, 15-Apr-2014
Amphetamine use is of concern because it causes a variety of devastating health physical and neurological consequences, including amphetamine-induced mental disorders.
- Treatment for amphetamine psychosis
Cochrane Systematic Reviews, 21-Jan-2009
Chronic amphetamine users may have experience of paranoia and hallucination. It has long been believed that dopamine antagonists, such as chlorpromazine, haloperidol, and thioridazine, are effective for the treatment of amphetamine psychosis.
- Treatment for amphetamine withdrawal
Cochrane Systematic Reviews, 15-Apr-2009
Few studies examined treatments for amphetamine withdrawal, although it is a common problem among amphetamine users. Its symptoms, in particular intense craving, may be a critical factor leading to relapse to amphetamine use. In clinical practice, medicat
- Treatment for anemia in people with AIDS
Cochrane Systematic Reviews, 5-Oct-2011
Anemia is common in persons with HIV infection and is associated with poor prognosis. There is a need to assess the effects of anemia treatments, and to determine whether these interventions are beneficial.
- Treatment for ascites in adults with decompensated liver cirrhosis: a network meta‐analysis
Cochrane Systematic Reviews, 16-Jan-2020
Approximately 20% of people with cirrhosis develop ascites. Several different treatments are available; including, among others, paracentesis plus fluid replacement, transjugular intrahepatic portosystemic shunts, aldosterone antagonists, and loop diureti
- Treatment for ataxia in multiple sclerosis
Cochrane Systematic Reviews, 21-Sep-2008
Disabling tremor or ataxia is common in multiple sclerosis (MS) and up to 80% of patients experience tremor or ataxia at some point during their disease. A variety of treatments are available, ranging from pharmacotherapy or stereotactic neurosurgery to n
- Treatment for avascular necrosis of bone in people with sickle cell disease
Cochrane Systematic Reviews, 5-Dec-2019
Avascular necrosis of bone is a frequent and severe complication of sickle cell disease and its treatment is not standardised. This is an update of a previously published Cochrane Review.
- Treatment for Barrett's oesophagus
Cochrane Systematic Reviews, 4-Mar-2021
- Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta‐analysis
Cochrane Systematic Reviews, 10-Apr-2021
Approximately 40% to 95% of people with liver cirrhosis have oesophageal varices. About 15% to 20% of oesophageal varices bleed within about one to three years after diagnosis. Several different treatments are available, including, among others, endoscopi
- Treatment for Charcot-Marie-Tooth disease
Cochrane Systematic Reviews, 28-Apr-2008
Charcot-Marie-Tooth disease (CMT) comprises a large variety of different forms of motor and sensory neuropathies. The most frequent are demyelinating forms (CMT1) and axonal forms (CMT2). The molecular basis of several CMT forms has been clarified during
